Teva Marion Copaxone launch price of $922 per month AWP is in mid-range of MS therapies.
Executive Summary
TEVA MARION COPAXONE LAUNCH PRICE OF $922.98 AWP PER MONTH places it in the mid-range of the marketed interferon beta multiple sclerosis therapies. Once-daily injectable Copaxone (glatiramer) is supplied in 32-vial packs of 20 mg each and includes an administration materials package. According to the "Red Book," Biogen's weekly injectable Avonex (interferon beta-1a) costs $852 AWP for a kit including four 30 mcg vials and administration materials, while Berlex' Betaseron (interferon beta-1b), which is dosed every other day, costs $1,080 AWP for a package of 15 vials of .3 mg each.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth